13.50
+0.19
+(1.43%)
At close: January 30 at 4:00:00 PM EST
13.01
-0.54
(-3.99%)
Pre-Market: 5:13:39 AM EST
Breakdown
12/31/2023
12/31/2022
Total Assets
7,548.00
16,524.00
Total Liabilities Net Minority Interest
82,031.00
110,301.00
Total Equity Gross Minority Interest
-74,483.00
-93,777.00
Total Capitalization
-74,483.00
-93,777.00
Common Stock Equity
-74,483.00
-93,777.00
Net Tangible Assets
-74,483.00
-93,777.00
Working Capital
5,188.00
10,742.00
Invested Capital
-74,483.00
-93,777.00
Tangible Book Value
-74,483.00
-93,777.00
Share Issued
11,221.31
11,221.31
Ordinary Shares Number
11,221.31
11,221.31
12/31/2022 - 1/2/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OKUR OnKure Therapeutics, Inc.
5.83
+10.42%
MLYS Mineralys Therapeutics, Inc.
10.27
-0.87%
ZBIO Zenas BioPharma, Inc.
7.62
+4.53%
MTVA MetaVia Inc.
1.8800
-0.53%
UR9.SG Clinuvel Pharmaceuticals Ltd
7.16
-0.49%
UTH.MU United Therapeutics Corp
343.80
-3.70%
ZLDAF Zelira Therapeutics Limited
0.3334
0.00%
FENC Fennec Pharmaceuticals Inc.
6.55
+1.24%
SEELQ Seelos Therapeutics, Inc.
0.0030
+2,900.00%
APGE Apogee Therapeutics, Inc.
42.50
+5.41%